{
    "Trade/Device Name(s)": [
        "Selux AST System",
        "Selux Gram-Negative Panel"
    ],
    "Submitter Information": "Selux Diagnostics, Inc.",
    "510(k) Number": "K211748",
    "Predicate Device Reference 510(k) Number(s)": [
        "K190905"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTT",
        "LTW"
    ],
    "Summary Letter Date": "April 19, 2023",
    "Summary Letter Received Date": "June 7, 2021",
    "Submission Date": "June 4, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Amikacin",
        "Amoxicillin-Clavulanate",
        "Ampicillin",
        "Ampicillin-Sulbactam",
        "Aztreonam",
        "Cefazolin",
        "Cefepime",
        "Cefoxitin",
        "Ceftazidime",
        "Ceftazidime-Avibactam",
        "Ceftriaxone",
        "Ciprofloxacin",
        "Eravacycline",
        "Ertapenem",
        "Gentamicin",
        "Imipenem-Relebactam",
        "Levofloxacin",
        "Meropenem",
        "Meropenem-Vaborbactam",
        "Minocycline",
        "Piperacillin-Tazobactam",
        "Tobramycin",
        "Trimethoprim-Sulfamethoxazole"
    ],
    "Specimen Type(s)": [
        "Isolated bacterial colonies from culture"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Selux AST System (includes Sample Prep Station, Inoculator, Analyzer, computer workstation)"
    ],
    "Method(s)/Technology(ies)": [
        "Automated growth-based detection",
        "Broth microdilution",
        "Fluorescence/optical absorbance",
        "Probe-based viability and surface area assays"
    ],
    "Methodologies": [
        "Determination of minimum inhibitory concentration (MIC)",
        "Serial two-fold dilution",
        "Automated inoculation and result reporting"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Analyzer",
        "Workstation",
        "Reagent",
        "Consumable",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Selux AST System, an automated antimicrobial susceptibility test platform for quantitative susceptibility testing of aerobic bacteria.",
    "Indications for Use Summary": "Automated system for quantitative or qualitative susceptibility testing of most clinically significant aerobic microorganisms; Gram-Negative Panel determines susceptibility of gram-negative bacilli to specific antimicrobial agents.",
    "fda_folder": "Microbiology"
}